Bringing new drugs and compounds to market has always been expensive, but it’s become increasingly so over the last decade. Considering that up to 90% of drug candidates never make it to market, the biotech and pharma industries have…
We use cookies to enhance site functionality, analyze traffic, and improve your browsing experience. You can accept all cookies, reject non-essential ones, or manage your preferences at any time. For more details, please see our Privacy Policy.